Mesoporous bioactive glass as a drug delivery system: Fabrication, bactericidal properties and biocompatibility

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 8, 2013, Pages 1951-1961

  Li, Yang ^a   Liu, Yi Zhuo ^b   Long, Teng ^a   Yu, Xi Bin ^b   Tang, Ting Ting ^a   Dai, Ke Rong ^a   Tian, Bo ^a   Guo, Ya Ping ^b   Zhu, Zhen An ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PROPERTIES; CONTROLLED DRUG DELIVERY SYSTEMS; DRUG-LOADING EFFICIENCY; HUMAN BONE MARROW STROMAL CELLS; IMPLANT-ASSOCIATED INFECTION; MESOPOROUS BIOACTIVE GLASS; PERI-IMPLANT INFECTIONS; SUSTAINED DRUG RELEASE;

ANTIBIOTICS; BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; MESOPOROUS MATERIALS;

BIOACTIVE GLASS;

GENTAMICIN; GLASS; MESOPOROUS BIOACTIVE GLASS; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BIOCOMPATIBILITY; BIOFILM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUSTAINED DRUG RELEASE;

ANTI-BACTERIAL AGENTS; BONE MARROW CELLS; CELLS, CULTURED; CERAMICS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; GENTAMICINS; HUMANS; MATERIALS TESTING; MICROBIAL SENSITIVITY TESTS; MICROTECHNOLOGY; POROSITY; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); LAKE VICTORIA MARBURGVIRUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84880824192     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4960-z     Document Type: Article

References (41)

1. Lu H, Kawazoe N, Kitajima T, Myoken Y, Tomita M, Umezawa A, Chen G, Ito Y. Spatial immobilization of bone morphogenetic protein-4 in a collagen-PLGA hybrid scaffold for enhanced osteoinductivity. Biomaterials. 2012;33:6140-6.
2. Liu X, Rahaman MN, Fu Q. Bone regeneration in strong porous bioactive glass (13-93) scaffolds with an oriented microstructure implanted in rat calvarial defects. Acta Biomater. 2013;9:4889-98.
3. Nguyen TH, Lee BT. In vitro and in vivo studies of rhBMP2-coated PS/PCL fibrous scaffolds for bone regeneration. J Biomed Mater Res A. 2013;101:797-808.
4. Venkatesan J, Pallela R, Bhatnagar I, Kim SK. Chitosan-amylopectin/ hydroxyapatite and chitosan-chondroitin sulphate/hydroxyapatite composite scaffolds for bone tissue engineering. Int J Biol Macromol. 2012;51:1033-42.
5. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-54.
6. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-9.
7. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167-93.
8. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials. 2007;28:4880-8.
9. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater. 2001;13:308-11.
10. Hou ZY, Li CX, Ma PA, Cheng ZY, Li XJ, Zhang X, et al. Up-conversion luminescent and porous NaYF4:Yb3 +, Er3 + @SiO2 nanocomposite fibers for anti-cancer drug delivery and cell imaging. Adv Funct Mater. 2012;22:2713-22.
11. Yang PP, Gai SL, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev. 2012;41:3679-98.
12. Li ZX, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev. 2012;41:2590-605.
13. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl. 2007;46:7548-58.
14. Carino IS, Pasqua L, Testa F, Aiello R, Puoci F, Iemma F, et al. Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv. 2007;14:491-5.
15. Wu C, Zhou Y, Lin C, Chang J, Xiao Y. Strontium-containing mesoporous bioactive glass scaffolds with improved osteogenic/cementogenic differentiation of periodontal ligament cells for periodontal tissue engineering. Acta Biomater. 2012;8:3805-15.
16. Cicuendez M, Portoles MT, Izquierdo-Barba I, Vallet-Regi M. New nanocomposite system with nanocrystalline apatite embedded into mesoporous bioactive glass. Chem Mater. 2012;24:1100-6.
17. Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release. 2006;110:522-30.
18. Salonen J, Kaukonen AM, Hirvonen J, Lehto VP. Mesoporous silicon in drug delivery applications. J Pharm Sci. 2008;97:632-53.
19. Khang D, Kim SY, Liu-Snyder P, Palmore GT, Durbin SM, Webster TJ. Enhanced fibronectin adsorption on carbon nanotube/poly(carbonate) urethane: independent role of surface nano-roughness and associated surface energy. Biomaterials. 2007;28:4756-68.
20. Wang CC, Hsu YC, Su FC, Lu SC, Lee TM. Effects of passivation treatments on titanium alloy with nanometric scale roughness and induced changes in fibroblast initial adhesion evaluated by a cytodetacher. J Biomed Mater Res A. 2009;88:370-83.
21. Woo KM, Chen VJ, Ma PX. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A. 2003;67:531-7.
22. Kay S, Thapa A, Haberstroh KM, Webster TJ. Nanostructured polymer/nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng. 2002;8:753-61.
23. Alcaide M, Portoles P, Lopez-Noriega A, Arcos D, Vallet-Regi M, Portoles MT. Interaction of an ordered mesoporous bioactive glass with osteoblasts, fibroblasts and lymphocytes, demonstrating its biocompatibility as a potential bone graft material. Acta Biomater. 2010;6:892-9.
24. Chavez VL, Song L, Barua S, Li X, Wu Q, Zhao D, Rege K, Vogt BD. Impact of nanopore morphology on cell viability on mesoporous polymer and carbon surfaces. Acta Biomater. 2010;6:3035-43.
25. Gentile F, La Rocca R, Marinaro G, Nicastri A, Toma A, Paonessa F, Cojoc G, Liberale C, Benfenati F, di Fabrizio E et al. Differential Cell Adhesion on Mesoporous Silicon Substrates. ACS Appl Mater Interfaces. 2012. doi: 10.1021/am300519a.
26. Zhang X, Wyss UP, Pichora D, Goosen MF. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J Pharm Pharmacol. 1994;46:718-24.
27. Arcos D, Ragel CV, Vallet-Regi M. Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials. 2001;22:701-8.
28. Tan H, Peng Z, Li Q, Xu X, Guo S, Tang T. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials. 2012;33:365-77.
29. Wu T, Hua X, He Z, Wang X, Yu X, Ren W. The bactericidal and biocompatible characteristics of reinforced calcium phosphate cements. Biomed Mater. 2012;7:045003.
30. Bjerkan G, Witso E, Bergh K. Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro. Acta Orthop. 2009;80:245-50.
31. O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB, Kolter R. Genetic approaches to study of biofilms. Methods Enzymol. 1999;310:91-109.
32. Sun H, Wu C, Dai K, Chang J, Tang T. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials. 2006;27:5651-7.
33. Wei G, Yan X, Yi J, Zhao L, Zhou L, Wang Y, Chengzhong Yu. Synthesis and in vitro bioactivity of mesoporous bioactive glasses with tunable macropores. Microporous Mesoporous Mater. 2011;143:157-65.
34. Sing KSW, Everett DH, Haul RAW, Moscou L, Pierotti RA, Rouquerol J, Siemieniewska T. Reporting physisorption data for gas/solid systems with Special reference to the determination of surface area and porosity. Pure & Appl Chem. 1985;4:603-19.
35. Ketonis C, Barr S, Adams CS, Hickok NJ, Parvizi J. Bacterial colonization of bone allografts: establishment and effects of antibiotics. Clin Orthop Relat Res. 2010;468:2113-21.
36. Patel JD, Ebert M, Ward R, Anderson JM. S. epidermidis biofilm formation. effects of biomaterial surface chemistry and serum proteins. J Biomed Mater Res A. 2007;80:742-51.
37. Oliveira M, Bexiga R, Nunes SF, Carneiro C, Cavaco LM, Bernardo F, Vilela CL. Biofilm-forming ability profiling of Staphylococcus aureus and Staphylococcus epidermidis mastitis isolates. Vet Microbiol. 2006;118:133-40.
38. Borsari V, Fini M, Giavaresi G, Tschon M, Chiesa R, Chiusoli L, Salito A, Rimondini L, Giardino R. Comparative in vivo evaluation of porous and dense duplex titanium and hydroxyapatite coating with high roughnesses in different implantation environments. J Biomed Mater Res A. 2009;89:550-60.
39. Rao JY, Hurst RE, Bales WD, Jones PL, Bass RA, Archer LT, Bell PB, Hemstreet GP 3rd. Cellular F-actin levels as a marker for cellular transformation: relationship to cell division and differentiation. Cancer Res. 1990;50:2215-20.
40. Kamegawa T, Masuda Y, Suzuki N, Horiuchi Y, Yamashita H. Design of single-site Ti embedded highly hydrophilic silica thin films with macro-mesoporous structures. ACS Appl Mater Interfaces. 2011;3:4561-5.
41. Bayram C, Demirbilek M, Caliskan N, Demirbilek ME, Denkbas EB. Osteoblast activity on anodized titania nanotubes: effect of simulated body fluid soaking time. J Biomed Nanotechnol. 2012;8:482-90. Materials